Genetics of frontotemporal dementia in China

References

• Olney NT, Spina S, Miller BL. Frontotemporal dementia. Neurol Clin. 2017;35:339–74.
   PubMed Web of Science ®Google Scholar
• Lomen-Hoerth C, Anderson T, Miller B. The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology 2002;59:1077–9.
   PubMed Web of Science ®Google Scholar
• Couratier P, Corcia P, Lautrette G, Nicol M, Marin B. ALS and frontotemporal dementia belong to a common disease spectrum. Rev Neurol. 2017;173:273–9.
   PubMed Web of Science ®Google Scholar
• Che XQ, Zhao QH, Huang Y, Li X, Ren RJ, Chen SD, et al. Mutation screening of the CHCHD2 gene for Alzheimer’s disease and frontotemporal dementia in Chinese mainland population. J Alzheimers Dis. 2018;61:1283–8.
   PubMed Web of Science ®Google Scholar
• Jiao B, Xiao T, Hou L, Gu X, Zhou Y, Zhou L, et al. High prevalence of CHCHD10 mutation in patients with frontotemporal dementia from China. Brain. 2016;139:e21.
   PubMed Web of Science ®Google Scholar
• Che XQ, Zhao QH, Huang Y, Li X, Ren RJ, Chen SD, et al. Genetic features of MAPT, GRN, C9orf72 and CHCHD10 gene mutations in Chinese patients with frontotemporal dementia. Curr Alzheimer Res. 2017;14:1102–8.
   PubMed Web of Science ®Google Scholar
• Greaves CV, Rohrer JD. An update on genetic frontotemporal dementia. J Neurol. 2019;266:2075–86.
   PubMed Web of Science ®Google Scholar
• Xu Y, Liu X, Shen J, Tian W, Fang R, Li B, et al. The whole exome sequencing clarifies the genotype- phenotype correlations in patients with early-onset dementia. Aging Dis. 2018;9:696–705.
   PubMed Web of Science ®Google Scholar
• Sellami L, Saracino D, Le Ber I. Genetic forms of frontotemporal lobar degeneration: current diagnostic approach and new directions in therapeutic strategies. Rev Neurol (Paris). 2020;176:571–81.
   PubMed Web of Science ®Google Scholar
• Sirkis DW, Geier EG, Bonham LW, Karch CM, Yokoyama JS. Recent advances in the genetics of frontotemporal dementia. Curr Genet Med Rep. 2019;7:41–52.
   PubMedGoogle Scholar
• Olszewska DA, Lonergan R, Fallon EM, Lynch T. Genetics of Frontotemporal Dementia. Curr Neurol Neurosci Rep. 2016;16:107.
   PubMed Web of Science ®Google Scholar
• Pottier C, Ravenscroft TA, Sanchez-Contreras M, Rademakers R. Genetics of FTLD: overview and what else we can expect from genetic studies. J Neurochem. 2016;138:32–53.
   PubMed Web of Science ®Google Scholar
• Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–24.
   PubMed Web of Science ®Google Scholar
• Lin HC, Lin CH, Chen PL, Cheng SJ, Chen PH. Intrafamilial phenotypic heterogeneity in a Taiwanese family with a MAPT p.R5H mutation: a case report and literature review. BMC Neurol. 2017;17:186.
   PubMed Web of Science ®Google Scholar
• Tang M, Gu X, Wei J, Jiao B, Zhou L, Zhou Y, et al. Analyses MAPT, GRN, and C9orf72 mutations in Chinese patients with frontotemporal dementia. Neurobiol Aging. 2016;46:235.e11–15.
   Web of Science ®Google Scholar
• Yang Y, Tang BS, Weng L, Li N, Shen L, Wang J, et al. Genetic identification is critical for the diagnosis of Parkinsonism: a Chinese pedigree with early onset of Parkinsonism. PloS One. 2015;10:e0136245.
   PubMed Web of Science ®Google Scholar
• Wu L, Liu J, Feng X, Dong J, Qin W, Liu Y, et al. 11C-CFT-PET in presymptomatic FTDP-17: a potential biomarker predicting onset. J Alzheimers Dis. 2018;61:613–8.
   PubMed Web of Science ®Google Scholar
• He S, Chen S, Xia MR, Sun ZK, Huang Y, Zhang JW. The role of MAPT gene in Chinese dementia patients: a P301L pedigree study and brief literature review. Neuropsychiatr Dis Treat. 2018;14:1627–33.
   PubMed Web of Science ®Google Scholar
• Shi Z, Liu S, Xiang L, Wang Y, Liu M, Liu S, et al. Frontotemporal dementia-related gene mutations in clinical dementia patients from a Chinese population. J Hum Genet. 2016;61:1003–8.
   PubMed Web of Science ®Google Scholar
• Sun L, Chen K, Li X, Xiao S. Rapidly progressive frontotemporal dementia associated with MAPT mutation G389R. J Alzheimers Dis. 2017;55:777–85.
   PubMed Web of Science ®Google Scholar
• Jiao B, Tang B, Liu X, Yan X, Zhou L, Yang Y, et al. Identification of C9orf72 repeat expansions in patients with amyotrophic lateral sclerosis and frontotemporal dementia in mainland China. Neurobiol Aging. 2014;35:936.e19–22.
   Web of Science ®Google Scholar
• He J, Tang L, Benyamin B, Shah S, Hemani G, Liu R, et al. C9orf72 hexanucleotide repeat expansions in Chinese sporadic amyotrophic lateral sclerosis. Neurobiol Aging. 2015;36:2660.e1–8.
   Web of Science ®Google Scholar
• Tsai CP, Soong BW, Tu PH, Lin KP, Fuh JL, Tsai PC, et al. A hexanucleotide repeat expansion in C9ORF72 causes familial and sporadic ALS in Taiwan. Neurobiol Aging. 2012;33:2232.e11–18.
   Web of Science ®Google Scholar
• Chen Y, Lin Z, Chen X, Cao B, Wei Q, Ou R, et al. Large C9orf72 repeat expansions are seen in Chinese patients with sporadic amyotrophic lateral sclerosis. Neurobiol Aging. 2016;38:217.e15–22.
   Web of Science ®Google Scholar
• Liu F, Liu Q, Lu CX, Cui B, Guo XN, Wang RR, et al. Identification of a novel loss-of-function C9orf72 splice site mutation in a patient with amyotrophic lateral sclerosis. Neurobiol Aging. 2016;47:219.e1–5.
   Web of Science ®Google Scholar
• Shen S, He J, Tang L, Zhang N, Fan D. CHCHD10 mutations in patients with amyotrophic lateral sclerosis in Mainland China. Neurobiol Aging. 2017;54:214.e7–10.
   Web of Science ®Google Scholar
• Zhou Q, Chen Y, Wei Q, Cao B, Wu Y, Zhao B, et al. Mutation screening of the CHCHD10 gene in chinese patients with amyotrophic lateral sclerosis. Mol Neurobiol. 2017;54:3189–94.
   PubMed Web of Science ®Google Scholar
• Gu JM, Ke YH, Yue H, Liu YJ, Zhang Z, Zhang H, et al. A novel VCP mutation as the cause of atypical IBMPFD in a Chinese family. Bone 2013;52:9–16.
   PubMed Web of Science ®Google Scholar
• Shu S, Li XL, Liu Q, Liu F, Cui B, Liu MS, et al. Screening of the TBK1 gene in familial and sporadic amyotrophic lateral sclerosis patients of Chinese origin. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17:605–7.
   PubMed Web of Science ®Google Scholar
• Yu H, Yu W, Luo SS, Yang YJ, Liu FT, Zhang Y, et al. Association of the TBK1 mutation p.Ile334Thr with frontotemporal dementia and literature review. Mol Genet Genomic Med. 2019;7:e547.
   PubMed Web of Science ®Google Scholar
• Tsai PC, Liu YC, Lin KP, Liu YT, Liao YC, Hsiao CT, et al. Mutational analysis of TBK1 in Taiwanese patients with amyotrophic lateral sclerosis. Neurobiol Aging. 2016;40:191.e11–16.
   Web of Science ®Google Scholar
• Jiao B, Sun Q, Yuan Z, Wang J, Zhou L, Yan X, et al. Rare TBK1 variants in patients with frontotemporal dementia and amyotrophic lateral sclerosis in a Chinese cohort. Transl Neurodegener. 2018;7:31.
   PubMed Web of Science ®Google Scholar
• Majounie E, Renton AE, Mok K, Dopper EGP, Waite A, Rollinson S, et al. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol. 2012;11:323–30.
   PubMed Web of Science ®Google Scholar
• Zou ZY, Zhou ZR, Che CH, Liu CY, He RL, Huang HP. Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2017;88:540–9.
   PubMed Web of Science ®Google Scholar
• Deleon J, Miller BL. Frontotemporal dementia. Handb Clin Neurol. 2018;148:409–30.
   PubMedGoogle Scholar
• Chaussenot A, Le Ber I, Ait-El-Mkadem S, Camuzat A, de Septenville A, Bannwarth S, et al. Screening of CHCHD10 in a French cohort confirms the involvement of this gene in frontotemporal dementia with amyotrophic lateral sclerosis patients. Neurobiol Aging. 2014;35:2884.e1–4.
   Web of Science ®Google Scholar
• Müller K, Andersen PM, Hübers A, Marroquin N, Volk AE, Danzer KM, et al. Two novel mutations in conserved codons indicate that CHCHD10 is a gene associated with motor neuron disease. Brain. 2014;137:e309.
   PubMed Web of Science ®Google Scholar
• Chiò A, Mora G, Sabatelli M, Caponnetto C, Traynor BJ, Johnson JO, et al. CHCH10 mutations in an Italian cohort of familial and sporadic amyotrophic lateral sclerosis patients. Neurobiol Aging. 2015;36:1767.e3–6.
   Web of Science ®Google Scholar
• Dols-Icardo O, Nebot I, Gorostidi A, Ortega-Cubero S, Hernández I, Rojas-García R, et al. Analysis of the CHCHD10 gene in patients with frontotemporal dementia and amyotrophic lateral sclerosis from Spain. Brain. 2015;138:e400.
   PubMed Web of Science ®Google Scholar
• Wong CH, Topp S, Gkazi AS, Troakes C, Miller JW, de Majo M, et al. The CHCHD10 P34S variant is not associated with ALS in a UK cohort of familial and sporadic patients. Neurobiol Aging. 2015;36:2908.e17–18.
   Web of Science ®Google Scholar
• Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, et al. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998;393:702–5.
   PubMed Web of Science ®Google Scholar
• van Swieten J, Spillantini MG. Hereditary frontotemporal dementia caused by Tau gene mutations. Brain Pathol. 2007;17:63–73.
   PubMed Web of Science ®Google Scholar
• Siuda J, Fujioka S, Wszolek ZK. Parkinsonian syndrome in familial frontotemporal dementia. Parkinsonism Relat Disord. 2014;20:957–64.
   PubMed Web of Science ®Google Scholar
• Bermingham N, Cowie TF, Paine M, Storey E, McLean C. Frontotemporal dementia and Parkinsonism linked to chromosome 17 in a young Australian patient with the G389R Tau mutation. Neuropathol Appl Neurobiol. 2008;34:366–70.
   PubMed Web of Science ®Google Scholar
• Chaunu MP, Deramecourt V, Buee-Scherrer V, Le Ber I, Brice A, Ehrle N, et al. Juvenile frontotemporal dementia with parkinsonism associated with tau mutation G389R. J Alzheimers Dis. 2013;37:769–76.
   PubMed Web of Science ®Google Scholar
• Tacik P, DeTure MA, Carlomagno Y, Lin WL, Murray ME, Baker MC, et al. FTDP-17 with Pick body-like inclusions associated with a novel tau mutation, p.E372G. Brain Pathol. 2017;27:612–26.
   PubMed Web of Science ®Google Scholar
• Hayashi S, Toyoshima Y, Hasegawa M, Umeda Y, Wakabayashi K, Tokiguchi S, et al. Late-onset frontotemporal dementia with a novel exon 1 (Arg5His) tau gene mutation. Ann Neurol. 2002;51:525–30.
   PubMed Web of Science ®Google Scholar
• Henz S, Ackl N, Knels C, Rominger A, Flatz W, Teipel S, et al. [A Pair of Siblings with a rare R5H-Mutation in Exon 1 of the MAPT-Gene]. Fortschr Neurol Psychiatr. 2015;83:397–401.
   PubMed Web of Science ®Google Scholar
• Giau VV, Senanarong V, Bagyinszky E, An SSA, Kim S. Analysis of 50 neurodegenerative genes in clinically diagnosed early-onset Alzheimer’s disease. Int J Mol Sci 2019;20:1514.
   Web of Science ®Google Scholar
• Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 2006;442:916–9.
   PubMed Web of Science ®Google Scholar
• Snowden JS, Pickering-Brown SM, Mackenzie IR, Richardson AM, Varma A, Neary D, et al. Progranulin gene mutations associated with frontotemporal dementia and progressive non-fluent aphasia. Brain. 2006;129:3091–102.
   PubMed Web of Science ®Google Scholar
• Mesulam M, Johnson N, Krefft TA, Gass JM, Cannon AD, Adamson JL, et al. Progranulin mutations in primary progressive aphasia: the PPA1 and PPA3 families. Arch Neurol. 2007;64:43–7.
   PubMedGoogle Scholar
• Rohrer JD, Crutch SJ, Warrington EK, Warren JD. Progranulin-associated primary progressive aphasia: a distinct phenotype? Neuropsychologia 2010;48:288–97.
   PubMed Web of Science ®Google Scholar
• Beck J, Rohrer JD, Campbell T, Isaacs A, Morrison KE, Goodall EF, et al. A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series. Brain. 2008;131:706–20.
   PubMed Web of Science ®Google Scholar
• DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011;72:245–56.
   PubMed Web of Science ®Google Scholar
• Renton AE, Majounie E, Waite A, Simón-Sánchez J, Rollinson S, Gibbs JR, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 2011;72:257–68.
   PubMed Web of Science ®Google Scholar
• Englund E, Gustafson L, Passant U, Majounie E, Renton AE, Traynor BJ, et al. Familial Lund frontotemporal dementia caused by C9ORF72 hexanucleotide expansion. Neurobiol Aging. 2012;33:1850.e13–16.
   Web of Science ®Google Scholar
• Gijselinck I, Van Langenhove T, van der Zee J, Sleegers K, Philtjens S, Kleinberger G, et al. A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study. The Lancet Neurology. 2012;11:54–65.
   PubMed Web of Science ®Google Scholar
• Mok K, Traynor BJ, Schymick J, Tienari PJ, Laaksovirta H, Peuralinna T, et al. Chromosome 9 ALS and FTD locus is probably derived from a single founder. Neurobiol Aging. 2012;33:209.e3–8.
   Web of Science ®Google Scholar
• van der Zee J, Gijselinck I, Dillen L, Langenhove TV, Theuns J, Engelborghs S, et al. A pan-European study of the C9orf72 repeat associated with FTLD: geographic prevalence, genomic instability, and intermediate repeats. Human Mut. 2013;34:363–73.
   PubMed Web of Science ®Google Scholar
• Au LWC, Wong A, Abrigo J, Yuen YP, Leung EYL, Mok VCT. Early-onset dementia in Chinese: demographic and etiologic characteristics. Neurology Asia 2019;24:139–46.
   Web of Science ®Google Scholar
• Zou ZY, Li XG, Liu MS, Cui LY. Screening for C9orf72 repeat expansions in Chinese amyotrophic lateral sclerosis patients. Neurobiol Aging. 2013;34:1710.e5–6.
   PubMed Web of Science ®Google Scholar
• Imai Y, Meng H, Shiba-Fukushima K, Hattori N. Twin CHCH proteins, CHCHD2, and CHCHD10: key molecules of Parkinson’s disease, amyotrophic lateral sclerosis, and frontotemporal dementia. Int J Mol Sci 2019;20:908.
   Web of Science ®Google Scholar
• Perrone F, Nguyen HP, Van Mossevelde S, Moisse M, Sieben A, Santens P, et al. Investigating the role of ALS genes CHCHD10 and TUBA4A in Belgian FTD-ALS spectrum patients. Neurobiol Aging. 2017;51:177.e9–16.
   Web of Science ®Google Scholar
• Zhou W, Ma D, Tan EK. Mitochondrial CHCHD2 and CHCHD10: roles in neurological diseases and therapeutic implications. Neuroscientist. 2020; 26:170–84.
   PubMed Web of Science ®Google Scholar
• McCann EP, Fifita JA, Grima N, Galper J, Mehta P, Freckleton SE, et al. Genetic and immunopathological analysis of CHCHD10 in Australian amyotrophic lateral sclerosis and frontotemporal dementia and transgenic TDP-43 mice. J Neurol Neurosurg Psychiatry. 2020;91:162–71.
   PubMed Web of Science ®Google Scholar
• Brockmann SJ, Freischmidt A, Oeckl P, Muller K, Ponna SK, Helferich AM, et al. CHCHD10 mutations p.R15L and p.G66V cause motoneuron disease by haploinsufficiency. Hum Mol Genet. 2018;27:706–15.
   PubMed Web of Science ®Google Scholar
• Genin EC, Plutino M, Bannwarth S, Villa E, Cisneros-Barroso E, Roy M, et al. CHCHD10 mutations promote loss of mitochondrial cristae junctions with impaired mitochondrial genome maintenance and inhibition of apoptosis. EMBO Mol Med. 2016;8:58–72.
   PubMed Web of Science ®Google Scholar
• Lehmer C, Schludi MH, Ransom L, Greiling J, Junghanel M, Exner N, et al. A novel CHCHD10 mutation implicates a Mia40-dependent mitochondrial import deficit in ALS. EMBO Mol Med. 2018;10:e8558.
   PubMed Web of Science ®Google Scholar
• Straub IR, Janer A, Weraarpachai W, Zinman L, Robertson J, Rogaeva E, et al. Loss of CHCHD10-CHCHD2 complexes required for respiration underlies the pathogenicity of a CHCHD10 mutation in ALS. Hum Mol Genet. 2018;27:178–89.
   PubMed Web of Science ®Google Scholar
• Burstein SR, Valsecchi F, Kawamata H, Bourens M, Zeng R, Zuberi A, et al. In vitro and in vivo studies of the ALS-FTLD protein CHCHD10 reveal novel mitochondrial topology and protein interactions. Hum Mol Genet. 2018;27:160–77.
   PubMed Web of Science ®Google Scholar
• Anderson CJ, Bredvik K, Burstein SR, Davis C, Meadows SM, Dash J, et al. ALS/FTD mutant CHCHD10 mice reveal a tissue-specific toxic gain-of-function and mitochondrial stress response. Acta Neuropathol. 2019;138:103–21.
   PubMed Web of Science ®Google Scholar
• Bannwarth S, Ait-El-Mkadem S, Chaussenot A, Genin EC, Lacas-Gervais S, Fragaki K, et al. A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement. Brain. 2014;137:2329–45.
   PubMed Web of Science ®Google Scholar
• Genin EC, Madji Hounoum B, Bannwarth S, Fragaki K, Lacas-Gervais S, Mauri-Crouzet A, et al. Mitochondrial defect in muscle precedes neuromuscular junction degeneration and motor neuron death in CHCHD10S59L/+ mouse. Acta Neuropathol. 2019;138:123–45.
   PubMed Web of Science ®Google Scholar
• Woo JA, Liu T, Trotter C, Fang CC, De Narvaez E, LePochat P, et al. Loss of function CHCHD10 mutations in cytoplasmic TDP-43 accumulation and synaptic integrity. Nat Commun. 2017;8:15558.
   PubMed Web of Science ®Google Scholar
• Li XL, Shu S, Li XG, Liu Q, Liu F, Cui B, et al. CHCHD10 is not a frequent causative gene in Chinese ALS patients. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17:458–60.
   PubMed Web of Science ®Google Scholar
• Meyer H, Weihl CC. The VCP/p97 system at a glance: connecting cellular function to disease pathogenesis. J Cell Sci. 2014;127:3877–83.
   PubMed Web of Science ®Google Scholar
• Ju JS, Weihl CC. Inclusion body myopathy, Paget’s disease of the bone and fronto-temporal dementia: a disorder of autophagy. Hum Mol Genet. 2010;19:R38–45.
   PubMed Web of Science ®Google Scholar
• Watts GD, Wymer J, Kovach MJ, Mehta SG, Mumm S, Darvish D, et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet. 2004;36:377–81.
   PubMed Web of Science ®Google Scholar
• Shinjo SK, Oba-Shinjo SM, Lerario AM, Marie SKN. A Brazilian family with inclusion body myopathy associated with Paget’s disease of bone and frontotemporal dementia linked to the VCP pGly97Glu mutation. Clin Rheumatol. 2018;37:1129–36.
   PubMed Web of Science ®Google Scholar
• Guinto JB, Ritson GP, Taylor JP, Forman MS. Valosin-containing protein and the pathogenesis of frontotemporal dementia associated with inclusion body myopathy. Acta Neuropathol. 2007;114:55–61.
   PubMed Web of Science ®Google Scholar
• Guyant-Maréchal L, Laquerrière A, Duyckaerts C, Dumanchin C, Bou J, Dugny F, et al. Valosin-containing protein gene mutations: clinical and neuropathologic features. Neurology 2006;67:644–51.
   PubMed Web of Science ®Google Scholar
• Freischmidt A, Wieland T, Richter B, Ruf W, Schaeffer V, Muller K, et al. Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia. Nat Neurosci. 2015;18:631–6.
   PubMed Web of Science ®Google Scholar
• Van Mossevelde S, Engelborghs S, van der Zee J, Van Broeckhoven C. Genotype-phenotype links in frontotemporal lobar degeneration. Nat Rev Neurol. 2018;14:363–78.
   PubMed Web of Science ®Google Scholar
• Borghero G, Pugliatti M, Marrosu F, Marrosu MG, Murru MR, Floris G, et al. TBK1 is associated with ALS and ALS-FTD in Sardinian patients. Neurobiol Aging. 2016;43:180.e1.
   Web of Science ®Google Scholar
• Funayama M, Ohe K, Amo T, Furuya N, Yamaguchi J, Saiki S, et al. CHCHD2 mutations in autosomal dominant late-onset Parkinson’s disease: a genome-wide linkage and sequencing study. The Lancet Neurology. 2015;14:274–82.
   PubMed Web of Science ®Google Scholar
• Shi C-H, Mao C-Y, Zhang S-Y, Yang J, Song B, Wu P, et al. CHCHD2 gene mutations in familial and sporadic Parkinson’s disease. Neurobiol Aging. 2016;38:217.e9–13.
   Web of Science ®Google Scholar
• Zhang W, Jiao B, Xiao T, Pan C, Liu X, Zhou L, et al. Mutational analysis of PRNP in Alzheimer’s disease and frontotemporal dementia in China. Sci Rep 2016;6:38435.
   PubMed Web of Science ®Google Scholar
• Pan C, Jiao B, Xiao T, Hou L, Zhang W, Liu X, et al. Mutations of CCNF gene is rare in patients with amyotrophic lateral sclerosis and frontotemporal dementia from Mainland China. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:265–8.
   PubMed Web of Science ®Google Scholar
• Gu X, Chen Y, Wei Q, Cao B, Ou R, Yuan X, et al. Mutation screening of the TIA1 gene in Chinese patients with amyotrophic lateral sclerosis/frontotemporal dementia. Neurobiol Aging. 2018;68:161.e1–3.
   Web of Science ®Google Scholar
• Yuan Z, Jiao B, Hou L, Xiao T, Liu X, Wang J, et al. Mutation analysis of the TIA1 gene in Chinese patients with amyotrophic lateral sclerosis and frontotemporal dementia. Neurobiol Aging. 2018;64:160.e9–12.
   Web of Science ®Google Scholar
• Qi X, Pang Q, Wang J, Zhao Z, Wang O, Xu L, et al. Familial early-onset Paget’s disease of bone associated with a novel hnRNPA2B1 mutation. Calcified Tissue International 2017;101:159–69.
   PubMed Web of Science ®Google Scholar